A hospital-based pharmacy intervention program for pneumococcal vaccination

Arch Intern Med. 1998 Jul 27;158(14):1543-7. doi: 10.1001/archinte.158.14.1543.

Abstract

Background: Current pneumococcal vaccination rates are well below national goals.

Objective: To determine whether pneumococcal vaccination rates could be increased with a hospital pharmacy-based program using simple chart reminders.

Methods: On a daily basis, inpatient records on general medicine and cardiology services at an academic medical center were reviewed to determine which patients were eligible to receive pneumococcal vaccine. Eligible inpatients were interviewed, and the percentage of nonvaccinated inpatients given vaccine during hospitalization was determined. During an intervention period, reminders were placed on charts after the interview requesting a vaccine when indicated.

Results: Of 447 inpatients, 224 (50.1%) had 1 or more indications for receiving pneumococcal vaccine. Only 64 (28.6%) had been previously vaccinated. One hundred fifty-eight (70.5%) of 224 vaccine-eligible patients had a prior hospitalization within the previous 5 years. Previous hospitalization was not significantly associated with having (48 [30.4%] of 158) or not having (16 [24.2%] of 66; P=.35) been vaccinated prior to admission. During the observational period, 0 of 80 vaccine-eligible, nonvaccinated inpatients were vaccinated before discharge. In comparison, 23 (28.8%) of 80 inpatients were vaccinated after a chart reminder (P<.001). During the intervention period, vaccination rates were 10-fold higher on general medicine services than on cardiology services.

Conclusions: A hospital-based pharmacy vaccination program that relied on simple chart reminders was significantly associated with increased vaccination rates among inpatients at risk for invasive pneumococcal disease.

MeSH terms

  • Bacterial Vaccines / administration & dosage*
  • Hospitals, Teaching
  • Humans
  • Medical Records*
  • Oklahoma
  • Pharmacy Service, Hospital*
  • Pneumococcal Infections / prevention & control*
  • Program Evaluation

Substances

  • Bacterial Vaccines